SCHEMBL6514770

SCHEMBL6514770

CCOC(=O)c1cc(S(=O)(=O)N(CC)Sc2ccc(Oc3ccc(CC)cc3)cc2)ccc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
RECQL P46063 1/20 0.41
LMNA P02545 4/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
ALDH1A1 P00352 4/20 0.36
TSHR P16473 2/20 0.36
KDM4E B2RXH2 2/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
HTT P42858 2/20 0.36
TP53 P04637 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HCRTR2 O43614 1/20 0.35
HCRTR1 O43613 1/20 0.35
CA12 O43570 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906314 0.93 ALDH1A1 (0.44) MAPTMEN1KMT2ARECQLLMNA
SCHEMBL4905300 0.91 POLB (0.43) LMNAL3MBTL1ALDH1A1TSHRSMN1; SMN2
SCHEMBL4894507 0.87 ALDH1A1 (0.48) MAPTMEN1KMT2ALMNAL3MBTL1
SCHEMBL4904025 0.86 ALDH1A1 (0.45) MAPTLMNAL3MBTL1ALDH1A1TSHR
SCHEMBL4902853 0.86 ALDH1A1 (0.45) MAPTMEN1KMT2ARECQLLMNA
SCHEMBL4905798 0.85 ALDH1A1 (0.44) MAPTMEN1KMT2ARECQLLMNA
SCHEMBL4902656 0.85 LMNA (0.44) MAPTMEN1KMT2ARECQLLMNA
SCHEMBL4902492 0.84 ALDH1A1 (0.40) MEN1KMT2ALMNAL3MBTL1ALDH1A1
SCHEMBL4906682 0.84 ALDH1A1 (0.48) MAPTKMT2ALMNAL3MBTL1ALDH1A1
SCHEMBL4904866 0.84 ALDH1A1 (0.43) MAPTMEN1KMT2ARECQLLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MAPT 1786/4885MEN1 4855/4885KMT2A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.